Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
about
QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording.Boosted protease inhibitors and the electrocardiographic measures of QT and PR durationsThe protease inhibitor atazanavir blocks hERG K(+) channels expressed in HEK293 cells and obstructs hERG protein transport to cell membraneUse of antineoplastic agents in patients with cancer who have HIV/AIDS.Short communication: Aging not gender is associated with high atazanavir plasma concentrations in Asian HIV-infected patients.The CASTLE study: atazanavir/r versus lopinavir/r in antiretroviral-naive patients.Protease inhibitor-associated QT interval prolongation.Prolongation of the QTc interval in HIV-infected individuals compared to the general population.Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.Atazanavir and chest pain.Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection.Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study.
P2860
Q34520166-23E210D9-C99C-4712-93E9-B8C3A2931650Q35034349-AE8806D6-3761-4AFF-88AB-9DB0FF1DB4E3Q35289501-3CC350A9-4144-4EAF-88D2-7B4756382C49Q35932561-7CE1699C-F8D9-4F1F-BD94-3EAE5ACA2EB8Q37359252-4C970B32-05B7-446D-AB64-61C7426EA8ECQ37593100-B82E3B16-D03C-46B4-9D62-F0962F6CE0F5Q37962886-B07C065F-DEE3-41F9-B0A4-15EC7B540A1FQ40095042-0BBF0ADA-76EE-4E4D-808A-9CA2E9BD6535Q41564295-DBDDCC04-70FD-44C5-B154-177B8E019A5AQ42223391-963E4F91-4E0A-43BB-A286-83E58DBE7CD6Q42263774-BA5838E4-A21C-4B8E-BB91-07C94ACC2D57Q42430296-DED7E3D1-C77D-4698-952F-533F5A829E69Q42990255-666B2986-C397-4D15-B3E3-D0E62BAADB50Q46107330-E492AF82-4B8F-4014-B72B-05BF46115C8B
P2860
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@ast
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@en
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@nl
type
label
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@ast
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@en
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@nl
prefLabel
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@ast
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@en
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@nl
P356
P1476
Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
@en
P2093
Maria Elena Ruiz
P356
10.1086/511875
P407
P577
2007-02-01T00:00:00Z